JP Morgan Chase’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.57M | Buy |
+30,000
| New | +$2.87M | ﹤0.01% | 3910 |
|
|
2025
Q3 | – | Sell |
-55,000
| Closed | -$4.79M | – | 7607 |
|
|
2025
Q2 | $4.79M | Sell |
55,000
-481,900
| -90% | -$40.9M | ﹤0.01% | 3211 |
|
|
2025
Q1 | $48.2M | Buy |
536,900
+495,500
| +1,197% | +$44.3M | ﹤0.01% | 1334 |
|
|
2024
Q4 | $3.31M | Sell |
41,400
-20,000
| -33% | -$1.73M | ﹤0.01% | 3750 |
|
|
2024
Q3 | $5.53M | Sell |
61,400
-139,200
| -69% | -$11.7M | ﹤0.01% | 3144 |
|
|
2024
Q2 | $15.8M | Buy |
200,600
+113,900
| +131% | +$9.34M | ﹤0.01% | 2047 |
|
|
2024
Q1 | $7.56M | Buy |
86,700
+70,000
| +419% | +$5.97M | ﹤0.01% | 2741 |
|
|
2023
Q4 | $1.38M | Sell |
16,700
-15,100
| -47% | -$1.15M | ﹤0.01% | 4118 |
|
|
2023
Q3 | $2.49M | Sell |
31,800
-7,500
| -19% | -$628K | ﹤0.01% | 3399 |
|
|
2023
Q2 | $3.46M | Buy |
+39,300
| New | +$3.38M | ﹤0.01% | 3140 |
|
|
2022
Q3 | – | Sell |
-11,600
| Closed | -$1.04M | – | 6692 |
|
|
2022
Q2 | $1.04M | Sell |
11,600
-45,300
| -80% | -$4.59M | ﹤0.01% | 4045 |
|
|
2022
Q1 | $6.31M | Sell |
56,900
-7,800
| -12% | -$824K | ﹤0.01% | 2810 |
|
|
2021
Q4 | $6.69M | Hold |
64,700
| – | – | ﹤0.01% | 2798 |
|
|
2021
Q3 | $8.11M | Sell |
64,700
-100
| -0.2% | -$12.9K | ﹤0.01% | 2589 |
|
|
2021
Q2 | $8.04M | Buy |
64,800
+32,000
| +98% | +$4.02M | ﹤0.01% | 2623 |
|
|
2021
Q1 | $3.88M | Buy |
32,800
+25,100
| +326% | +$2.94M | ﹤0.01% | 3192 |
|
|
2020
Q4 | $902K | Hold |
7,700
| – | – | ﹤0.01% | 4029 |
|
|
2020
Q3 | $791K | Hold |
7,700
| – | – | ﹤0.01% | 3766 |
|
|
2020
Q2 | $706K | Buy |
7,700
+600
| +8% | +$57.5K | ﹤0.01% | 3700 |
|
|
2020
Q1 | $640K | Sell |
7,100
-26,800
| -79% | -$2.85M | ﹤0.01% | 3695 |
|
|
2019
Q4 | $3.85M | Buy |
33,900
+30,000
| +769% | +$3.29M | ﹤0.01% | 2896 |
|
|
2019
Q3 | $424K | Sell |
3,900
-150,000
| -97% | -$15.7M | ﹤0.01% | 4243 |
|
|
2019
Q2 | $15M | Hold |
153,900
| – | – | ﹤0.01% | 1781 |
|
|
2019
Q1 | $14M | Sell |
153,900
-44,400
| -22% | -$3.97M | ﹤0.01% | 1792 |
|
|
2018
Q4 | $18M | Buy |
198,300
+10,600
| +6% | +$991K | ﹤0.01% | 1557 |
|
|
2018
Q3 | $18.5M | Sell |
187,700
-68,500
| -27% | -$6.33M | ﹤0.01% | 1725 |
|
|
2018
Q2 | $21.9M | Buy |
256,200
+8,500
| +3% | +$710K | ﹤0.01% | 1517 |
|
|
2018
Q1 | $19.9M | Sell |
247,700
-55,900
| -18% | -$4.61M | ﹤0.01% | 1513 |
|
|
2017
Q4 | $24.5M | Buy |
303,600
+258,900
| +579% | +$20.7M | 0.01% | 1431 |
|
|
2017
Q3 | $3.47M | Sell |
44,700
-105,300
| -70% | -$8.74M | ﹤0.01% | 2829 |
|
|
2017
Q2 | $13.3M | Buy |
+150,000
| New | +$12.6M | ﹤0.01% | 1752 |
|
|
2016
Q4 | – | Sell |
-1,314,756
| Closed | -$114M | – | 5077 |
|
|
2016
Q3 | $114M | Hold |
1,314,756
| – | – | 0.03% | 522 |
|
|
2016
Q2 | $114M | Buy |
1,314,756
+6,756
| +0.5% | +$546K | 0.03% | 527 |
|
|
2016
Q1 | $98.1M | Buy |
+1,308,000
| New | +$98.5M | 0.03% | 546 |
|
|
2015
Q4 | – | Sell |
-135,700
| Closed | -$9.08M | – | 4755 |
|
|
2015
Q3 | $9.08M | Buy |
+135,700
| New | +$9.99M | ﹤0.01% | 1840 |
|
|
2015
Q1 | – | Sell |
-440,000
| Closed | -$31.8M | – | 4191 |
|
|
2014
Q4 | $31.8M | Buy |
440,000
+415,000
| +1,660% | +$28.8M | 0.01% | 1193 |
|
|
2014
Q3 | $1.55M | Sell |
25,000
-10,000
| -29% | -$636K | ﹤0.01% | 3083 |
|
|
2014
Q2 | $2.23M | Buy |
+35,000
| New | +$2.13M | ﹤0.01% | 2472 |
|
Other funds holding MDT
VCM
VPM
JP Morgan Chase's MDT Position: Q1 2026 in Review
JP Morgan Chase reduced its Medtronic (MDT) stake by 4.9% in Q1 2026, selling an estimated $253M and leaving 50,973,541 shares worth $4.37B. The position accounts for 0.28% of the portfolio, ranked #76.
JP Morgan Chase first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.15B in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- JP Morgan Chase held 50,973,541 shares of Medtronic worth $4.37B as of Q1 2026.
- JP Morgan Chase sold 2,643,153 Medtronic shares in Q1 2026, an estimated $253M.
- Medtronic made up 0.28% of JP Morgan Chase's portfolio in Q1 2026, its #76 holding.
- JP Morgan Chase first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Medtronic position peaked at $5.15B in Q4 2025.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.